OBJECTIVE—The A1C assay, expressed as the percent of hemoglobin that is glycated,
measures chronic glycemia and is widely used to judge the adequacy of diabetes treatment and …

… Walker, DNSc., and David M. Nathan, MD) takes responsibility for the content of this
article. Address reprint requests to the Diabetes Prevention Program Coordinating Center, …

Context: Metabolic risk conferred by adiposity may be due to associated risk factor clustering.
Objective: The objective of this study was to assess risk for diabetes or cardiovascular …

The consensus algorithm for the medical management of type 2 diabetes was published in
August 2006 with the expectation that it would be updated, based on the availability of new …

Type 2 diabetes is now epidemic. In the US, there has been a 61% increase in incidence
between 1990 and 2001 (1). There are currently 1.5 million new cases per year, and the …

The epidemic of type 2 diabetes in the latter part of the 20th and in the early 21st century,
and the recognition that achieving specific glycemic goals can substantially reduce morbidity, …

Diabetes mellitus is a disease of metabolic dysregulation, most notably abnormal glucose
metabolism, accompanied by characteristic long-term complications. The complications that …

OBJECTIVE The Diabetes Control and Complications Trial (DCCT) was designed to test the
glucose hypothesis and determine whether the complications of type 1 diabetes (T1DM) …

BACKGROUND Multiple laboratory tests are used to diagnose and manage patients with
diabetes mellitus. The quality of the scientific evidence supporting the use of these tests varies …

BACKGROUND Despite growing evidence that bariatric/metabolic surgery powerfully
improves type 2 diabetes (T2D), existing diabetes treatment algorithms do not include surgical …